Victoza is a once-daily injectable medication that contains liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It is used to improve blood sugar control in people with type 2 diabetes and to help reduce the risk of cardiovascular events in patients with both diabetes and heart disease. Victoza may also assist with weight loss in some individuals. It is often used alongside diet and exercise and can be combined with other antidiabetic medications.

Mechanism of Action
Liraglutide mimics the action of the natural hormone GLP-1, which plays a vital role in glucose regulation. It works through the following mechanisms:

• Stimulates insulin release from the pancreas in response to elevated blood sugar

• Suppresses glucagon secretion, which reduces the liver’s release of glucose

• Slows gastric emptying, leading to reduced post-meal glucose spikes

• Promotes a feeling of fullness, which can help with appetite control and weight loss

  Uses
  Victoza is prescribed for:

  • Improving blood sugar control in adults and children aged 10 years and older with type 2 diabetes

  • Reducing the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes and established heart disease

  • Supporting weight loss in overweight individuals with diabetes as part of a broader lifestyle change plan

    Adverse Effects
    While Victoza is effective and generally safe, it can have side effects, especially when starting the medication.

    Common side effects:

    • Nausea

    • Diarrhoea

    • Vomiting

    • Constipation

    • Loss of appetite